In addition to replicating and expanding on existing work, this study may further contribute to the field of PGx by investigating a potential hypothesis contributing to the lack of conclusive results in PGx studies examining CYP2D6 and treatment outcomes of drugs for psychosis. This evidence concerns the gene CYP2D6 and psychotic disorder.